Campto 100 mg Injection
  1. Home
  2. Pharma Products
  3. Pfizer Ltd
  4. Campto 100 mg Injection

Campto 100 mg Injection

Campto 100 mg Injection contains irinotecan hydrochloride trihydrate, a chemotherapy medicine used mainly for advanced or metastatic colorectal cancer. It works by inhibiting topoisomerase I, an enzyme needed for cancer cell DNA replication. The medicine is administered as an intravenous infusion by a qualified healthcare professional.

BUY NOW

Category

Campto 100 mg Injection is supplied as a 20 mg/mL concentrate in a 5 mL vial containing 100 mg of irinotecan hydrochloride trihydrate. It may be used alone or in combination with other anticancer medicines depending on the prescribed treatment regimen. The concentrate must be diluted before intravenous infusion according to the product instructions. Treatment dosage and schedule are determined by the oncology specialist based on the patient’s condition and treatment protocol.

Technical Specification

Specification Details
Active Ingredient Irinotecan Hydrochloride Trihydrate 100 mg
Concentration 20 mg/mL
Dosage Form Concentrate for Solution for Infusion
Vial Volume 5 mL
Therapeutic Class Topoisomerase I Inhibitor
Route of Administration Intravenous Infusion

Product Also Known As

Campto 100 mg Injection, Campto 100 mg/5 mL Injection, Campto Irinotecan 100 mg Injection, Irinotecan 100 mg Injection, Irinotecan Hydrochloride 100 mg Injection, Irinotecan Oncology Injection